Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Ribback

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Gastroenterology|May 24, 2016
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer CellsEngin Gürlevik, Bettina Fleischmann-Mundt, Jennifer Brooks, et al.
Gastroenterology|February 20, 2013
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinomaDarjus Felix Tschaharganeh, Xin Chen, Philipp Latzko, et al.
Gastroenterology|April 30, 2022
β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in CholangiocarcinomaYi Zhang, Hongwei Xu, Guofei Cui, et al.
Hepatology (Baltimore, Md.)|April 4, 2017
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesisPin Liu, Mengmeng Ge, Junjie Hu, et al.
Gut|April 8, 2019
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humansLi Che, Wenna Chi, Yu Qiao, et al.
Genome Medicine|September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyFlorian A Büttner, Stefan Winter, Viktoria Stühler, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Journal of Hepatology|July 23, 2017
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in miceShanshan Zhang, Xinhua Song, Dan Cao, et al.
Gastroenterology|August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal AdenocarcinomaUjjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Gastroenterology|May 24, 2016
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer CellsEngin Gürlevik, Bettina Fleischmann-Mundt, Jennifer Brooks, et al.
Gastroenterology|February 20, 2013
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinomaDarjus Felix Tschaharganeh, Xin Chen, Philipp Latzko, et al.
Gastroenterology|April 30, 2022
β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in CholangiocarcinomaYi Zhang, Hongwei Xu, Guofei Cui, et al.
Hepatology (Baltimore, Md.)|April 4, 2017
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesisPin Liu, Mengmeng Ge, Junjie Hu, et al.
Gut|April 8, 2019
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humansLi Che, Wenna Chi, Yu Qiao, et al.
Genome Medicine|September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyFlorian A Büttner, Stefan Winter, Viktoria Stühler, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Journal of Hepatology|July 23, 2017
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in miceShanshan Zhang, Xinhua Song, Dan Cao, et al.
Gastroenterology|August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal AdenocarcinomaUjjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
Pageof 10